Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/01

Trade details

Type
Insider sale
Amount
$2,186,903.34
Shares · price
3,826 sh · $571.59 a share
Held after
44,633 sh
Trade date
26/04/30
Filed
26/05/01
Days to filing
1 days

Sold 7.9% of holdings

Share of holding sold
7.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 03/31~05/30

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Planned sale10b5-1 planUnited Therapeutics

    $113.3M

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $2.2M of United Therapeutics UTHR · 7.9% of holdings · 10b5-1 plan | Whalegun